# Listen: Is 23andMe Trading Your DNA? With Maria Liu from First Health Advisory Solutions

Published 2018-08-10 · Updated 2026-07-23 · Healthcare on MarketScale
Canonical: https://www.marketscale.com/industries/healthcare/listen-is-23andme-trading-your-dna-with-maria-liu-from-first-health-advisory-solutions
Creator hub: First Health Advisory

> 23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies. As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about…

23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies.

As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about the security concerns and potential worries that come with companies sharing medical data.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

**Follow us on social media for the latest updates in B2B!**

Twitter – [@HealthMKSL](https://twitter.com/HEALTHmksl)

Facebook – [facebook.com/marketscale](http://facebook.com/marketscale)

LinkedIn – [linkedin.com/company/marketscale](http://linkedin.com/company/marketscale)

---
Source: MarketScale, https://www.marketscale.com/industries/healthcare/listen-is-23andme-trading-your-dna-with-maria-liu-from-first-health-advisory-solutions. Published for AI indexing and citation; cite the canonical URL. Site guide for agents: https://www.marketscale.com/llms.txt